Helix Biopharma Corp HBP
Shares issued 13,743,415 Apr 25 close $1.00
Mon 28 Apr 97 Financial Statements
STATEMENT OF EARNINGS
Six months ended January 31
1997 1996
Revenue $ 3,918,605 $ 3,897,551
----------- -----------
Expenses
Marketing and
administration 2,375,956 1,318,637
Amortization 109,207 80,487
Interest and
bank charges,
net (87,219) (9,172)
Interest on
long term debt 14,577 24,641
Royalties 167,646 94,916
Production 2,174,855 1,998,842
Rent 58,759 50,022
----------- -----------
4,813,781 3,558,373
----------- -----------
Earnings (loss)
before the
undernoted) (895,175) 339,178
----------- -----------
Research and
development 399,200 192,832
Investment tax
credits and
grants - 21,721
Gain on sale of
capital assets - (1,918)
----------- -----------
399,200 212,635
----------- -----------
Earnings (loss)
before income
taxes (1,294,375) 126,543
Income taxes - 1,058
----------- -----------
Net earnings
(loss) $(1,294,375) $ 125,485
=========== ===========
(c) Copyright 1997 Canjex Publishing Ltd. canada-stockwatch.com |
